A detailed history of Sherbrooke Park Advisers LLC transactions in Natera, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 1,275 shares of NTRA stock, worth $183,523. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,275
Previous 1,759 27.52%
Holding current value
$183,523
Previous $223 Million 9.62%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$117.67 - $174.0 $56,952 - $84,216
-484 Reduced 27.52%
1,275 $202 Million
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $171,942 - $228,089
1,759 New
1,759 $223 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.